Page 326 - SAMRC AnnualReport 2025-26

ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026
NOTES TO THE ANNUAL FINANCIAL STATEMENTS
(CONTINUED)

12. Living resources

31 MARCH 2026 31 MARCH 2025
ACCUMULATED ACCUMULATED
COST/ IMPAIRMENT CARRYING COST/ IMPAIRMENT CARRYING
VALUATION LOSSES VALUE VALUATION LOSSES VALUE
R R R R R R
Rhesus monkey 950,173 (298,246) 651,927 892,806 (273,395) 619,411
Vervet monkeys 931,882 (337,066) 594,816 943,332 (328,758) 614,574
Total 1,882,055 (635,312) 1,246,743 1,836,138 (602,153) 1,233,985

Reconciliation of living resources – 31 March 2026
OPENING DEPRE-
BALANCE ADDITIONS DISPOSALS CIATION TOTAL
R R R R R
Rhesus monkey 619,411 95,334 (26,356) (36,462) 651,927
Vervet monkeys 614,574 64,212 (52,802) (31,168) 594,816
1,233,985 159,546 (79,158) (67,630) 1,246,743

Reconciliation of living resources – 31 March 2025
OPENING DEPRE-
BALANCE ADDITIONS DISPOSALS CIATION TOTAL
R R R R R
Rhesus monkey 525,360 152,535 (26,157) (32,327) 619,411
Vervet monkeys 537,679 128,424 (21,307) (30,222) 614,574
1,063,039 280,959 (47,464) (62,549) 1,233,985

The last selling price per animal type was used to determine the fair value as there is not an active market for
these animals.

13. Interests in controlled entities

Investments in controlled entities

CARRYING CARRYING
AMOUNT AMOUNT
% HOLDING % HOLDING
NAME OF COMPANY HELD BY 31 MARCH 2026 31 MARCH 2025 31 MARCH 2026 31 MARCH 2025
Medres (Pty)Ltd SAMRC 100.00% 100.00% 1 1
Jirehsa Medical (Pty) Ltd Medres (Pty)Ltd 42.00% 42.00% 1 1
2 2

The carrying amounts of controlled entities are shown net of impairment losses.
The financial statements of Medres (Pty) Ltd and Jirehsa Medical (Pty) Ltd have not been consolidated with those
of the SAMRC, as they are not considered material in the context of SAMRC.
Controlled entities with less than 50% voting powers held.
Although the entity holds less than 50% of the voting powers in Jirehsa Medical (Pty) Ltd the investment is
considered a controlled entity because SAMRC has the power to govern the financial and operating policies of
Jirehsa Medical (Pty) Ltd.

324 SA M R C A N N U A L R EP O R T 2 0 2 5 / 2 0 2 6